Impedimed Ltd has released a press release.
Strategic Realignment
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- Appendix 4D and Interim Report Ended 31 December 2015
- A$75M Private Placement and A$7.5M Share Purchase Plan
- Appendix 4C - Quarter Ended 31 December 2015
Later from Impedimed
- Appendix 4C - Quarter Ended 31 March 2016
- Five Year Multi-Location Clinical Trial with Mayo Clinic
- Medicare Proposes New Reimbursement Rates, L-Dex Increases
- Vanderbilt to Begin Testing Next Generation Device
- Relationship with Redox to Expand EHR Integration Capability
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed